Back

Where are we going? Population health and the VICTORION programme

27 August 2023 (13:15 - 13:30)
Organised by: Logo
Congress Presentation Part of: Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran? Lipid-Lowering Agents Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Where are we now? Decision-making in LDL-C lowering and CV risk
Professor J. Jukema (Leiden, NL)
Slides Video
Presentation thumbnail
What have we learned? Long-term safety and efficacy of inclisiran
Professor R. Wright (Rochester, US)
Slides Video
Presentation thumbnail
Q&A and meeting close
Professor J. Jukema (Leiden, NL) Professor K. Ray (London, GB) Professor R. Wright (Rochester, US)
Slides Video

Access the full session

Session thumbnail
Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Session
Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran?
thumbnail
Congress Session
Sustained LDL-C reduction: from long-term trials to real-world implementation
thumbnail
Congress Session
Cardiovascular disease management in the UK versus other European countries

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources